-DOCSTART- -X- O
Rotavirus -X- _ O
is -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
main -X- _ O
causes -X- _ O
of -X- _ O
acute -X- _ O
diarrhea -X- _ O
and -X- _ O
enteritis -X- _ O
in -X- _ O
infants. -X- _ B-Patient
Currently -X- _ O
, -X- _ O
studies -X- _ O
are -X- _ O
underway -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
use -X- _ O
of -X- _ O
probiotics -X- _ O
to -X- _ O
improve -X- _ O
rotavirus -X- _ O
vaccine -X- _ O
protection. -X- _ O
A -X- _ O
previous -X- _ O
work -X- _ O
demonstrated -X- _ O
that -X- _ O
the -X- _ O
probiotic -X- _ O
strain -X- _ O
Bifidobacterium -X- _ B-Intervention
longum -X- _ I-Intervention
subsp. -X- _ I-Intervention
infantis -X- _ I-Intervention
CECT -X- _ I-Intervention
7210 -X- _ I-Intervention
is -X- _ O
able -X- _ O
to -X- _ O
hinder -X- _ O
rotavirus -X- _ O
replication -X- _ O
both -X- _ O
in -X- _ O
vitro -X- _ O
and -X- _ O
in -X- _ O
vivo. -X- _ O
The -X- _ O
present -X- _ O
study -X- _ O
takes -X- _ O
a -X- _ O
systematic -X- _ O
approach -X- _ O
in -X- _ O
order -X- _ O
to -X- _ O
identify -X- _ O
the -X- _ O
molecule -X- _ O
directly -X- _ O
involved -X- _ O
in -X- _ O
rotavirus -X- _ O
inhibition. -X- _ O
Supernatant -X- _ O
protease -X- _ O
digestions -X- _ O
revealed -X- _ O
both -X- _ O
the -X- _ O
proteinaceous -X- _ O
nature -X- _ O
of -X- _ O
the -X- _ O
active -X- _ O
substance -X- _ O
and -X- _ O
the -X- _ O
fact -X- _ O
that -X- _ O
the -X- _ O
molecule -X- _ O
responsible -X- _ O
for -X- _ O
inhibiting -X- _ O
rotavirus -X- _ O
replication -X- _ O
is -X- _ O
released -X- _ O
to -X- _ O
the -X- _ O
supernatant. -X- _ O
Following -X- _ O
purification -X- _ O
by -X- _ O
cationic -X- _ O
exchange -X- _ O
chromatography -X- _ O
, -X- _ O
active -X- _ O
fractions -X- _ O
were -X- _ O
obtained -X- _ O
and -X- _ O
the -X- _ O
functional -X- _ O
compound -X- _ O
was -X- _ O
identified -X- _ O
as -X- _ O
an -X- _ O
11-amino -X- _ O
acid -X- _ O
peptide -X- _ O
( -X- _ O
MHQPHQPLPPT -X- _ O
, -X- _ O
named -X- _ O
11-mer -X- _ B-Outcome
peptide -X- _ I-Outcome
) -X- _ O
with -X- _ O
a -X- _ O
molecular -X- _ O
mass -X- _ O
of -X- _ O
1.282 -X- _ O
KDa. -X- _ O
The -X- _ O
functionality -X- _ O
of -X- _ O
11-mer -X- _ O
was -X- _ O
verified -X- _ O
using -X- _ O
the -X- _ O
synthesized -X- _ O
peptide -X- _ O
in -X- _ O
Wa -X- _ B-Comparison
, -X- _ I-Comparison
Ito -X- _ I-Comparison
, -X- _ I-Comparison
and -X- _ I-Comparison
VA70 -X- _ I-Comparison
rotavirus -X- _ I-Comparison
infections -X- _ I-Comparison
of -X- _ I-Comparison
both -X- _ I-Comparison
HT-29 -X- _ I-Comparison
and -X- _ I-Comparison
MA-104 -X- _ I-Comparison
cell -X- _ I-Comparison
lines. -X- _ I-Comparison
Finally -X- _ O
, -X- _ O
protease -X- _ O
activity -X- _ O
was -X- _ O
detected -X- _ O
in -X- _ O
B. -X- _ O
longum -X- _ O
subsp. -X- _ O
infantis -X- _ O
CECT -X- _ O
7210 -X- _ O
supernatant -X- _ O
, -X- _ O
which -X- _ O
releases -X- _ O
11-mer -X- _ B-Outcome
peptide. -X- _ I-Outcome
A -X- _ O
preliminary -X- _ O
identification -X- _ O
of -X- _ O
the -X- _ O
protease -X- _ O
is -X- _ O
also -X- _ O
included -X- _ O
in -X- _ O
the -X- _ O
study -X- _ O
. -X- _ O

